Research Article

Beneficial Effects of Aminoguanidine on Skin Flap Survival in Diabetic Rats

Table 2

Measured glucose and HbA1c levels and body weight in the groups.

GroupsGlucose (mg/dL)HbA1c (%)Body weight (g)

Group I: Control

First day (before STZ administration)145,76 ± 39,263,80 ± 0,16206,23 ± 54,22
5th day (5 days after STZ administration)140,23 ± 31,66 3,78 ± 0,12199,30 ± 50,96
Before flap elevation174,00 ± 30,75 3,95 ± 0,26197,00 ± 12,98
7th day (7 days after flap elevation)145,69 ± 35,87 4,21 ± 0,39195,23 ± 17,09

Group II: AG

First day (before STZ administration)135,12 ± 43,363,92 ± 0,26210,37 ± 52,08
5th day (5 days after STZ administration)136,00 ± 41,82 3,93 ± 0,26209,12 ± 50,31
Before flap elevation153,37 ± 24,64 3,93 ± 0,64194,87 ± 38,84
7th day (7 days after flap elevation)149,12 ± 28,72 4,50 ± 0,63192,75 ± 38,46

Group III: DM

First day (before STZ administration)125,00 ± 30,433,93 ± 0,29208,83 ± 52,8
5th day (5 days after STZ administration)395,83 ± 79,83 5,30 ± 0,55192,16 ± 50,02
Before flap elevation306,33 ± 101,79 8,30 ± 1,46182,16 ± 43,23
7th day (7 days after flap elevation)450,83 ± 165,73 9,45 ± 2,50170,16 ± 42,70

Group IV: DM + AG

First day (before STZ administration)153,16 ± 45,103,91 ± 0,29207,83 ± 53,03
5th day (5 days after STZ administration)382,83 ± 51,54 5,30 ± 0,55192,33 ± 49,65
Before flap elevation373,00 ± 124,96 7,98 ± 1,38188,83 ± 44,56
7th day (7 days after flap elevation)455,16 ± 109,57 8,20 ± 0,80187,16 ± 44,00